FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977447249> ?p ?o ?g. }

• W1977447249 endingPage "268" @default.
• W1977447249 startingPage "257" @default.
• W1977447249 abstract "To investigate the cumulative incidence of and the risk factors for developing second malignant neoplasms (SMN) in children and adolescents following treatment for relapse of acute lymphocytic leukaemia (ALL).Patients (1376) up to 18 years of age with first relapse of non-B-cell ALL were treated and achieved a 2nd complete remission (CR). The treatment followed trial protocol in five consecutive multicentre trials of the ALL-REZ BFM Study Group between March 1983 and December 2001. The incidence of SMN was analysed, correlated with clinical and therapeutic parameters, and compared to the age-specific incidence rates of cancers as cited in German cancer registries.Out of the 1376 patients 21 were diagnosed with SMN including non-lymphoblastic leukaemia/myelodysplastic syndrome (n=6), osteo-/Ewing's-/fibroblastic sarcoma (n=4), B-cell ALL/lymphoma (n=2), thyroid carcinoma (n=2), basal cell carcinoma, adeno carcinoma, squamous cell carcinoma, meningioma, malignant histiocytosis, glioblastoma and anaplastic astrocytoma (n=1 each). The overall cumulative risk of SMN at 15 years (median follow-up of 13.1 years) was 1.26%+/-0.38% (SE). SMN was found to be significantly associated with stem cell transplantation (SCT), and high cumulative doses of cranial irradiation, etoposide and cyclophosphamide. In multivariate analysis etoposide (VP16) and cyclophophamide (CY) were found to be independently associated with SMN (p=0.047 and 0.002). Compared to the incidence of neoplasm in the age-matched population, there was a 10-fold increase of neoplasia.Despite repeated exposure to intense frontline and relapse treatment (including multiagent chemotherapy, cranial irradiation and stem cell transplantation in some patients) the cumulative incidence of SMN was unexpectedly low, though significantly higher than in the general age-matched population. The association of SMN to SCT seemed to be a secondary effect at least partially mediated by exposure to high doses of VP16 and CY given for conditioning therapy." @default.
• W1977447249 created "2016-06-24" @default.
• W1977447249 creator A5000426144 @default.
• W1977447249 creator A5002273933 @default.
• W1977447249 creator A5022986622 @default.
• W1977447249 creator A5030679532 @default.
• W1977447249 creator A5060432679 @default.
• W1977447249 creator A5067719280 @default.
• W1977447249 creator A5073379037 @default.
• W1977447249 creator A5086181841 @default.
• W1977447249 creator A5086360848 @default.
• W1977447249 date "2008-01-01" @default.
• W1977447249 modified "2023-10-18" @default.
• W1977447249 title "Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood" @default.
• W1977447249 cites W1847176704 @default.
• W1977447249 cites W1854117681 @default.
• W1977447249 cites W1868055647 @default.
• W1977447249 cites W1883916287 @default.
• W1977447249 cites W1905050374 @default.
• W1977447249 cites W1933695467 @default.
• W1977447249 cites W1971325547 @default.
• W1977447249 cites W2002678366 @default.
• W1977447249 cites W2005221830 @default.
• W1977447249 cites W2007532842 @default.
• W1977447249 cites W2014375779 @default.
• W1977447249 cites W2021318922 @default.
• W1977447249 cites W2022645679 @default.
• W1977447249 cites W2023126822 @default.
• W1977447249 cites W2023719828 @default.
• W1977447249 cites W2025743629 @default.
• W1977447249 cites W2073140442 @default.
• W1977447249 cites W2075627103 @default.
• W1977447249 cites W2085129932 @default.
• W1977447249 cites W2089807299 @default.
• W1977447249 cites W2107317577 @default.
• W1977447249 cites W2126142122 @default.
• W1977447249 cites W2129279704 @default.
• W1977447249 cites W2141316364 @default.
• W1977447249 cites W2147996630 @default.
• W1977447249 cites W2168571815 @default.
• W1977447249 cites W2169278972 @default.
• W1977447249 cites W2200883957 @default.
• W1977447249 cites W2320188351 @default.
• W1977447249 cites W2333611917 @default.
• W1977447249 cites W2342320434 @default.
• W1977447249 cites W2400758460 @default.
• W1977447249 cites W2410117880 @default.
• W1977447249 cites W30310674 @default.
• W1977447249 cites W3041047318 @default.
• W1977447249 cites W4210969505 @default.
• W1977447249 cites W4232032536 @default.
• W1977447249 cites W4238048948 @default.
• W1977447249 doi "https://doi.org/10.1016/j.ejca.2007.09.019" @default.
• W1977447249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17981026" @default.
• W1977447249 hasPublicationYear "2008" @default.
• W1977447249 type Work @default.
• W1977447249 sameAs 1977447249 @default.
• W1977447249 citedByCount "63" @default.
• W1977447249 countsByYear W19774472492012 @default.
• W1977447249 countsByYear W19774472492013 @default.
• W1977447249 countsByYear W19774472492015 @default.
• W1977447249 countsByYear W19774472492016 @default.
• W1977447249 countsByYear W19774472492017 @default.
• W1977447249 countsByYear W19774472492018 @default.
• W1977447249 countsByYear W19774472492019 @default.
• W1977447249 countsByYear W19774472492022 @default.
• W1977447249 countsByYear W19774472492023 @default.
• W1977447249 crossrefType "journal-article" @default.
• W1977447249 hasAuthorship W1977447249A5000426144 @default.
• W1977447249 hasAuthorship W1977447249A5002273933 @default.
• W1977447249 hasAuthorship W1977447249A5022986622 @default.
• W1977447249 hasAuthorship W1977447249A5030679532 @default.
• W1977447249 hasAuthorship W1977447249A5060432679 @default.
• W1977447249 hasAuthorship W1977447249A5067719280 @default.
• W1977447249 hasAuthorship W1977447249A5073379037 @default.
• W1977447249 hasAuthorship W1977447249A5086181841 @default.
• W1977447249 hasAuthorship W1977447249A5086360848 @default.
• W1977447249 hasConcept C126322002 @default.
• W1977447249 hasConcept C143998085 @default.
• W1977447249 hasConcept C2776694085 @default.
• W1977447249 hasConcept C2778119113 @default.
• W1977447249 hasConcept C2779562246 @default.
• W1977447249 hasConcept C2908647359 @default.
• W1977447249 hasConcept C2911091166 @default.
• W1977447249 hasConcept C45393284 @default.
• W1977447249 hasConcept C500558357 @default.
• W1977447249 hasConcept C71924100 @default.
• W1977447249 hasConcept C88879693 @default.
• W1977447249 hasConcept C90924648 @default.
• W1977447249 hasConcept C99454951 @default.
• W1977447249 hasConceptScore W1977447249C126322002 @default.
• W1977447249 hasConceptScore W1977447249C143998085 @default.
• W1977447249 hasConceptScore W1977447249C2776694085 @default.
• W1977447249 hasConceptScore W1977447249C2778119113 @default.
• W1977447249 hasConceptScore W1977447249C2779562246 @default.
• W1977447249 hasConceptScore W1977447249C2908647359 @default.
• W1977447249 hasConceptScore W1977447249C2911091166 @default.
• W1977447249 hasConceptScore W1977447249C45393284 @default.

• next